133 related articles for article (PubMed ID: 25028743)
1. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics.
Taylor M; Jakacki R; May C; Howrie D; Maurer S
Am J Hosp Palliat Care; 2015 Dec; 32(8):841-8. PubMed ID: 25028743
[TBL] [Abstract][Full Text] [Related]
2. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
Amin P; Roeland E; Atayee R
J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
[TBL] [Abstract][Full Text] [Related]
3. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
4. Patient-controlled analgesia for children at home.
Mherekumombe MF; Collins JJ
J Pain Symptom Manage; 2015 May; 49(5):923-7. PubMed ID: 25546288
[TBL] [Abstract][Full Text] [Related]
5. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain.
Kajiume T; Sera Y; Nakanuno R; Ogura T; Karakawa S; Kobayakawa M; Taguchi S; Oshita K; Kawaguchi H; Sato T; Kobayashi M
J Palliat Med; 2012 Jun; 15(6):719-22. PubMed ID: 22401313
[TBL] [Abstract][Full Text] [Related]
6. Use of continuous intravenous ketamine for end-stage cancer pain in children.
Conway M; White N; Jean CS; Zempsky WT; Steven K
J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature.
Kamp J; Van Velzen M; Olofsen E; Boon M; Dahan A; Niesters M
Expert Opin Drug Metab Toxicol; 2019 Dec; 15(12):1033-1041. PubMed ID: 31693437
[No Abstract] [Full Text] [Related]
8. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.
Mak P; Broadbear JH; Kolosov A; Goodchild CS
Pain Med; 2015 Sep; 16(9):1781-93. PubMed ID: 25800174
[TBL] [Abstract][Full Text] [Related]
9. Pain management in fulminating ulcerative colitis.
White M; Shah N; Lindley K; Lloyd-Thomas A; Thomas M
Paediatr Anaesth; 2006 Nov; 16(11):1148-52. PubMed ID: 17040304
[TBL] [Abstract][Full Text] [Related]
10. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.
Lynch ME; Clark AJ; Sawynok J; Sullivan MJ
J Pain; 2005 Oct; 6(10):644-9. PubMed ID: 16202956
[TBL] [Abstract][Full Text] [Related]
11. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
Kong PE; Snijdelaar DG; Crul BJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
[TBL] [Abstract][Full Text] [Related]
12. Intranasal ketamine for analgesia in the emergency department: a prospective observational series.
Andolfatto G; Willman E; Joo D; Miller P; Wong WB; Koehn M; Dobson R; Angus E; Moadebi S
Acad Emerg Med; 2013 Oct; 20(10):1050-4. PubMed ID: 24127709
[TBL] [Abstract][Full Text] [Related]
13. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain.
Dougherty M; DeBaun MR
J Pediatr; 2003 Apr; 142(4):373-6. PubMed ID: 12712053
[TBL] [Abstract][Full Text] [Related]
14. Adjunct continuous intravenous ketamine infusion for postoperative pain relief following posterior spinal instrumentation for correction of scoliosis: a case report.
Tsui BC; Wagner A; Mahood J; Moreau M
Paediatr Anaesth; 2007 Apr; 17(4):383-6. PubMed ID: 17359410
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of ketamine tablets for treatment of patients with neuropathic pain].
Yanagihara Y; Ohtani M; Matsumoto M; Kariya S; Uchino K; Hiraishi T; Ashizawa N; Aoyama T; Yamamura Y; Iga T
Yakugaku Zasshi; 1999 Dec; 119(12):980-7. PubMed ID: 10630103
[TBL] [Abstract][Full Text] [Related]
16. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
Finkel JC; Pestieau SR; Quezado ZM
J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
[TBL] [Abstract][Full Text] [Related]
17. Side effects of ketamine in the long-term treatment of neuropathic pain.
Cvrcek P
Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Ketamine for Rapid Opioid Dose Reduction, Reversal of Opioid-Induced Neurotoxicity, and Pain Control in Terminal Care: Case Report and Literature Review.
Winegarden J; Carr DB; Bradshaw YS
Pain Med; 2016 Apr; 17(4):644-9. PubMed ID: 26234740
[TBL] [Abstract][Full Text] [Related]
19. Treatment of central post-stroke pain with oral ketamine.
Vick PG; Lamer TJ
Pain; 2001 May; 92(1-2):311-3. PubMed ID: 11323153
[TBL] [Abstract][Full Text] [Related]
20. Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion.
Bosma RL; Cheng JC; Rogachov A; Kim JA; Hemington KS; Osborne NR; Venkat Raghavan L; Bhatia A; Davis KD
Anesthesiology; 2018 Nov; 129(5):1015-1024. PubMed ID: 30199420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
